From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis Article

sustainable development goals

authors

publication date

  • 2014

webpage

published in

keywords

  • anti-tumor necrosis factor-alfa
  • biologic therapy
  • cyclosporine
  • hepatitis B
  • methotrexate
  • psoriasis
  • ustekinumab

start page

  • 178

end page

  • 186

volume

  • 70

issue

  • 1